首页> 外文OA文献 >PUK16 Reduced Use of Erythropoiesis-Stimulating Agents and Intravenous Iron with Use of the Phosphate Binder Ferric Citrate: a Facility-Level Cost-Offset Model Under the Medicare Bundle

【2h】

PUK16 Reduced Use of Erythropoiesis-Stimulating Agents and Intravenous Iron with Use of the Phosphate Binder Ferric Citrate: a Facility-Level Cost-Offset Model Under the Medicare Bundle

机译：PUK16减少使用促红细胞生成剂和静脉注射铁的同时使用磷酸盐结合剂柠檬酸铁：Medicare配套下的设施级成本补偿模型

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Mutell R.; Rubin J.L.; Bond T.C.; Mayne T.;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Reduced use of erythropoiesis-stimulating agents and intravenous iron with ferric citrate: a managed care cost-offset model [J] . Richard Mutell, Jaime L Rubin, T Christopher Bond, International Journal of Nephrology and Renovascular Disease . 2013,第6期

机译：减少使用促红细胞生成剂和柠檬酸铁静脉注射铁：可管理的医疗费用抵消模型
2. Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD [J] . Kausik Umanath, Diana I. Jalal, Barbara A. Greco, Journal of the American Society of Nephrology: JASN . 2015,第10期

机译：柠檬酸铁减少ESRD中静脉铁和促红细胞生成剂的使用
3. Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD [J] . Umanath Kausik, Jalal Diana I., Greco Barbara A., Journal of the American Society of Nephrology: JASN . 2015,第10期

机译：柠檬酸铁减少ESRD中静脉铁和促红细胞生成剂的使用
4. Thermodynamic modelling of phosphate and chloride effects on solid and solution phase ferric iron speciation [C] . O. H. Tuovinen, P. Nurmi, L. Ahonen International Biohydrometallurgy Symposium . 2009

机译：磷酸盐和氯化物对固体和溶液相铁的影响的热力学建模
5. Reduced use of erythropoiesis-stimulating agents and intravenous iron with ferric citrate: a managed care cost-offset model [O] . Richard Mutell, Jaime L Rubin, T Christopher Bond, 2013

机译：减少使用促红细胞生成剂和柠檬酸铁静脉注射铁：可管理的医疗费用抵消模型
6. PUK15 a Managed Care Cost-Offset Model for Ferric Citrate, an Experimental Phosphate Binder That Can Reduce the Use of Erythropoiesis-Stimulating Agents and Intravenous Iron in Hemodialysis Patients with Hyperphosphatemia [O] . Mutell R., Rubin J.L., Bond T.C., 2012

机译：PUK15柠檬酸铁的管理式医疗费用抵消模型，一种实验性磷酸盐结合剂，可减少高磷血症血液透析患者的红细胞生成刺激剂和静脉内铁的使用

PUK16 Reduced Use of Erythropoiesis-Stimulating Agents and Intravenous Iron with Use of the Phosphate Binder Ferric Citrate: a Facility-Level Cost-Offset Model Under the Medicare Bundle

著录项

引文网络

相似文献

相关主题

期刊订阅